Jim Simons Mirum Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q3 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 513,448 shares of MIRM stock, worth $36.7 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

513,448

Previous 396,348 29.54%

Holding current value

$36.7 Million

Previous $20.2 Million 86.61%

% of portfolio

0.05%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$48.39 - $77.69 $5.67 Million - $9.1 Million	117,100 Added 29.54%	513,448 $37.6 Million
Q2 2025 Aug 13, 2025	BUY	$38.39 - $51.11 $7.98 Million - $10.6 Million	207,848 Added 110.26%	396,348 $20.2 Million
Q1 2025 May 14, 2025	BUY	$41.32 - $53.16 $3.61 Million - $4.64 Million	87,252 Added 86.18%	188,500 $8.49 Million
Q4 2024 Feb 13, 2025	BUY	$37.85 - $46.65 $1.54 Million - $1.9 Million	40,800 Added 67.5%	101,248 $4.19 Million
Q3 2024 Nov 13, 2024	BUY	$33.68 - $44.74 $2.04 Million - $2.7 Million	60,448 New	60,448 $2.36 Million
Q4 2023 Feb 13, 2024	SELL	$27.14 - $34.93 $272,811 - $351,116	-10,052 Reduced 14.63%	58,648 $1.73 Million
Q3 2023 Nov 14, 2023	BUY	$24.63 - $32.85 $1.41 Million - $1.88 Million	57,100 Added 492.24%	68,700 $2.17 Million
Q2 2023 Aug 11, 2023	SELL	$23.51 - $30.09 $47,020 - $60,180	-2,000 Reduced 14.71%	11,600 $300,000
Q1 2023 May 12, 2023	SELL	$19.19 - $24.1 $1.53 Million - $1.92 Million	-79,700 Reduced 85.42%	13,600 $327,000
Q4 2022 Feb 13, 2023	BUY	$17.59 - $23.83 $1.64 Million - $2.22 Million	93,300 New	93,300 $1.82 Million
Q2 2022 Aug 12, 2022	BUY	$18.42 - $27.5 $152,886 - $228,250	8,300 Added 25.0%	41,500 $808,000
Q1 2022 May 13, 2022	BUY	$15.5 - $23.93 $74,400 - $114,864	4,800 Added 16.9%	33,200 $731,000
Q4 2021 Feb 11, 2022	SELL	$13.05 - $19.35 $90,045 - $133,515	-6,900 Reduced 19.55%	28,400 $453,000
Q3 2021 Nov 12, 2021	SELL	$13.95 - $20.18 $196,695 - $284,538	-14,100 Reduced 28.54%	35,300 $703,000
Q2 2021 Aug 13, 2021	BUY	$15.84 - $20.6 $782,496 - $1.02 Million	49,400 New	49,400 $854,000
Q1 2021 May 13, 2021	SELL	$16.29 - $21.92 $698,841 - $940,368	-42,900 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$15.75 - $25.45 $675,675 - $1.09 Million	42,900 New	42,900 $749,000
Q3 2020 Nov 13, 2020	SELL	$18.4 - $26.59 $239,199 - $345,670	-13,000 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$11.51 - $20.97 $149,630 - $272,610	13,000 New	13,000 $253,000

Others Institutions Holding MIRM

# of Institutions

291

Shares Held

57.6M

Call Options Held

86.1K

Put Options Held

105K

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $2.63B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account